455 related articles for article (PubMed ID: 6636797)
1. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
Hirsch H
Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
[TBL] [Abstract][Full Text] [Related]
2. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
4. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
Longo G; Poli F; Strinati R; Longo F
Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
6. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
Branica S; Vrabec B; Francetić I; Bakran I
Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
[TBL] [Abstract][Full Text] [Related]
7. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
McKenzie S; Baillie E
J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
[TBL] [Abstract][Full Text] [Related]
8. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
Ahrens J
Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
[TBL] [Abstract][Full Text] [Related]
9. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
Wettengel R; Oellerich M; Schnitker J
Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424
[TBL] [Abstract][Full Text] [Related]
10. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
Eitner L; Wettengel R; Schnitker J
Prax Klin Pneumol; 1983 Jun; 37(6):236-42. PubMed ID: 6889277
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
Rasmussen FV; Waldorff S; Madsen L
Eur J Respir Dis; 1984 Jan; 65(1):20-7. PubMed ID: 6705854
[TBL] [Abstract][Full Text] [Related]
14. [Clinical use of theophylline retard Oranienburg].
Slapke J; Hummel S; Wilke A; Wenz W; Meister W; Förster R; Wiesner B; Rentsch E; Nussbücker B
Z Erkr Atmungsorgane; 1988; 170(1):49-53. PubMed ID: 3291417
[TBL] [Abstract][Full Text] [Related]
15. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
16. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
[TBL] [Abstract][Full Text] [Related]
17. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Logvinoff MM; Weinstein DB; Watts MT; Seifert B
Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
[TBL] [Abstract][Full Text] [Related]
19. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
[No Abstract] [Full Text] [Related]
20. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
